FI970717A - Menetelmät kohtusyövän inhiboimiseksi - Google Patents

Menetelmät kohtusyövän inhiboimiseksi Download PDF

Info

Publication number
FI970717A
FI970717A FI970717A FI970717A FI970717A FI 970717 A FI970717 A FI 970717A FI 970717 A FI970717 A FI 970717A FI 970717 A FI970717 A FI 970717A FI 970717 A FI970717 A FI 970717A
Authority
FI
Finland
Prior art keywords
methods
uterine cancer
inhibiting uterine
inhibiting
cancer
Prior art date
Application number
FI970717A
Other languages
English (en)
Swedish (sv)
Other versions
FI970717A0 (fi
Inventor
Susan Margaret Boss
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI970717A0 publication Critical patent/FI970717A0/fi
Publication of FI970717A publication Critical patent/FI970717A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
FI970717A 1994-08-22 1997-02-20 Menetelmät kohtusyövän inhiboimiseksi FI970717A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29385394A 1994-08-22 1994-08-22
PCT/US1995/010651 WO1996005833A1 (en) 1994-08-22 1995-08-21 Methods of inhibiting endometrial cancer

Publications (2)

Publication Number Publication Date
FI970717A0 FI970717A0 (fi) 1997-02-20
FI970717A true FI970717A (fi) 1997-02-20

Family

ID=23130867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970717A FI970717A (fi) 1994-08-22 1997-02-20 Menetelmät kohtusyövän inhiboimiseksi

Country Status (17)

Country Link
EP (1) EP0777476A4 (fi)
JP (1) JPH10504824A (fi)
KR (1) KR970705387A (fi)
AU (1) AU688112B2 (fi)
CA (1) CA2198119A1 (fi)
CZ (1) CZ51897A3 (fi)
FI (1) FI970717A (fi)
HU (1) HUT76890A (fi)
IL (1) IL115022A (fi)
MX (1) MX9701327A (fi)
MY (1) MY113757A (fi)
NO (1) NO970783L (fi)
NZ (1) NZ292017A (fi)
RU (1) RU2161964C2 (fi)
TW (1) TW404834B (fi)
WO (1) WO1996005833A1 (fi)
ZA (1) ZA956994B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) * 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
KR20160066490A (ko) * 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 헤테로사이클 유도체 및 그의 용도
CN115825414B (zh) * 2023-01-09 2023-04-25 中国医学科学院北京协和医院 血液或尿液代谢标志物及其在子宫内膜癌早筛中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
WO1994023068A1 (en) * 1993-04-07 1994-10-13 Ligand Pharmaceuticals, Incorporated Method for screening for receptor agonists
JPH07149638A (ja) * 1993-10-15 1995-06-13 Eli Lilly & Co 耐性新生物の治療法
ZA956988B (en) * 1994-08-22 1997-02-21 Lilly Co Eli Methods of inhibiting primary endometrial hyperplasia.
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Also Published As

Publication number Publication date
AU3370095A (en) 1996-03-14
NO970783D0 (no) 1997-02-20
KR970705387A (ko) 1997-10-09
NZ292017A (en) 2000-07-28
IL115022A (en) 2000-07-31
TW404834B (en) 2000-09-11
FI970717A0 (fi) 1997-02-20
MX9701327A (es) 1997-05-31
ZA956994B (en) 1997-02-21
CZ51897A3 (en) 1997-06-11
EP0777476A4 (en) 1999-06-23
HUT76890A (en) 1997-12-29
AU688112B2 (en) 1998-03-05
JPH10504824A (ja) 1998-05-12
MY113757A (en) 2002-05-31
IL115022A0 (en) 1998-06-15
NO970783L (no) 1997-02-20
EP0777476A1 (en) 1997-06-11
CA2198119A1 (en) 1996-02-29
WO1996005833A1 (en) 1996-02-29
RU2161964C2 (ru) 2001-01-20

Similar Documents

Publication Publication Date Title
DE69513175D1 (de) Hydrathemmung
FI963597A (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
NO962901L (no) Fremgangsmåte for enkelttur-komplettering
BR9509436A (pt) Inibidores de síntese de apoliproteina-B
NO301445B1 (no) Anordning for sleping
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
IS5035A (is) Aðferðir til varnar gegn brjóstakrabbameini
NO305341B1 (no) Anordning for elektro-fisking
IDP000008233A (id) Metode pencegahan kanker payudara
FI970717A (fi) Menetelmät kohtusyövän inhiboimiseksi
FI971197A0 (fi) Menetelmät kohdun limakalvon mitoosien inhiboimiseksi
DE9419763U1 (de) Verteilerblock
KR960000746U (ko) 제침기겸용 커터
KR960010058U (ko) 미끄럼틀
DE9411502U1 (de) Zurichtstreifen
UA1534S (uk) Нижня білизна - грація для жінок
KR950027027U (ko) 앨범용 내지
SE9402900D0 (sv) Glidgatan
NO964439L (no) Fôr
NO960756D0 (no) For
LV11117A (lv) Ierice locisanai
UA27887C2 (uk) Пристрій для рефлексотерапії
FI952759A0 (fi) Rapumerta